Mandate

Vinge advises Sleep Cycle AB (publ) in connection with the listing on Nasdaq Stockholm

Vinge advises Sleep Cycle AB (publ) (“Sleep Cycle” or the “Company”) in connection with the listing on Nasdaq Stockholm. The offering circular was published on 28 May 2021 and the first day of trading on Nasdaq Stockholm was 8 June 2021.

The offering price was SEK 70 per share, corresponding to a market value of Sleep Cycle of approximately SEK 1.3bn. The offering comprised 4,870,171 shares, of which 1,428,571 are newly issued shares and 3,441,600 are existing shares.

Sleep Cycle is a market leading sleep tracking application with a mission to empower people to sleep better to improve global health. Sleep Cycle uses a patented AI-based audio technology to measure users’ sleep and provide personalized insights based on the Company’s sleep database. Sleep Cycle was founded in 2009 and is headquartered in Gothenburg, Sweden.

Vinge’s team mainly consisted of Jesper Schönbeck, Linnéa Sellström, Joel Magnusson and Lorin Arabi (Capital Markets and Public M&A), Matthias Pannier, Vilhelm Rondahl and Mikaela Falkner (M&A), Victor Ericsson, Henrik Wastenson and Jonathan Riddersholm (Corporate tax), Stojan Arnestål and Felizia Wiker (IP) and Ebba Svenburg (Employment and Benefits).

Related

Vinge advises Pricer AB in connection with its issuance of senior unsecured bonds and early redemption

Vinge advises Pricer AB (publ) in connection with its issuance of floating rate senior unsecured bonds of SEK 300 million within a framework of SEK 500 million and early redemption of existing bonds.
December 10, 2024

Vinge advises Carasent in connection with the listing on Nasdaq Stockholm

Vinge advises Carasent AB (publ) in connection with the listing on Nasdaq Stockholm. The listing is made through a reverse cross-border merger, whereby Carasent AB takes over Carasent ASA, previously listed on Oslo Stock Exchange.
December 09, 2024

Vinge has advised Apotea in connection with its listing on Nasdaq Stockholm

Vinge has advised Apotea AB (publ) (“Apotea”) in connection with its listing on Nasdaq Stockholm. The prospectus was published on November 26, 2024 and the first day of trading is December 6, 2024.
December 06, 2024